WebMD Health Corp.
-
Banking on a Buyout
By Jon Quast - March 25, 2013 | Tickers: AVP, BBRY, DIS, WBMD
Aug. 30, 2009, is a day my portfolio will not soon forget. That was the day I lost my largest holding. The day that the company I believed in more than any other was taken from me. The company that had the largest potential for growth was absorbed into another. It was the day that Disney (NYSE: DIS) announced they were buying my beloved Marvel.
I'm not exactly a more »
-
The Problem with WebMD
By Jon Quast - March 21, 2013 | Tickers: FB, GRPN, WBMD
WebMD (NASDAQ: WBMD) is a health information service best known for its website of the same name. This company has been very popular lately, with visits up nearly 50% in the last month. Yet this company has a serious problem. I believe Jim Cramer said it best: "This is expensive, and it doesn't make a lot of money."
As an investor, I am very interested in the bottom line more »
-
Google's Notable Investment Risks
By Ishfaque Faruk - February 27, 2013 | Tickers: GOOG, MSFT, QIHU, WBMD, YELP
The mighty Google (NASDAQ: GOOG) has long been the most dominant Internet firm for a while now. And over time, its footprint has expanded into numerous other areas as well. With Google's stock trading near all-time highs, the stock still has a decent amount of upside.
Before buying into the Google story, the material investment risks should be evaluated carefully. Investors should be well aware of the dark sides more »
-
CEOs Are Buying These Stocks (Part I)
By Anh HOANG - February 15, 2013 | Tickers: CPSI, FCF, WBMD
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Peter Lynch
According to Peter Lynch, investors should follow insiders’ buys closely in order to pick the right investment opportunities. In February, there were four CEOs who bought shares of their own companies, including First Commonwealth Financial Group (NYSE: FCF), Computer Programs and Systems (NASDAQ: CPSI), Bally more »
-
Battle over "Mobile Healthcare"
By Mike Thiessen - January 15, 2013 | Tickers: ATHN, EPOC, WBMD
Electronic health record and practice management provider Athenahealth (NASDAQ: ATHN) recently announced its intention to purchase mobile medical-reference and "point-of-care" provider Epocrates (NASDAQ: EPOC) for about $293 million in cash. Under the terms of the formal offer, San Mateo, California-based Epocrates shareholders would receive cash payouts of $11.75 per share. No options or purchase warrants would be extended or exchanged. Depending upon the speed with which it is approved more »
-
Notable Upgrades Last Friday That Could Have Lingering Effects
By Brian Nichols - December 17, 2012 | Tickers: BV, MU, WBMD, YOKU
As the year comes to an end there are more and more investors becoming pessimistic that we will not find a solution to the fiscal cliff. As a result, the markets have begun to trade more volatile and will most likely trade lower as the date approaches. However, there are several stocks that might see a trend higher in the coming weeks. These are all stocks that had an upgrade more »
-
A Large Hedge Fund Nabs a Board Seat at This Internet Company
By Meena Krishnamsetty - October 21, 2012 | Tickers: ACOM, AOL, TRIP, WBMD, YELP
Kensico Capital Management owned 5.7 million shares of WebMD Health Corp. ) at the end of June (find more stocks Kensico owned). According to a recent 13D filed with the SEC, Thomas Coleman, an executive at Kensico (which is managed by Michael Lowenstein), has now joined the Board of Directors; his Board seat was a new addition and so no directors were removed. The health and wellness information website has more »
-
Dr. Oz has transformed the wellness-industrial complex
By sylvia kronstadt - August 8, 2012 | Tickers: GNC, SNE, WBMD, WTW
Products mentioned on the show "have a habit of being conspicuously absent from store shelves the day after being blasted into notoriety by Dr. Oz," Forbes magazine says. "Is the TV doctor trend creating a nation of heath-disordered people? Do we have unrealistic expectations of health, by being constantly bombarded by the latest secrets, tips, and fads?"
-
Is WebMD a Good Stock to Buy Right Now?
By Meena Krishnamsetty - April 18, 2012 | Tickers: EPOC, WBMD
The Healthcare Information Technology (HCIT) sector has traded well into the 30.0x forward multiple range in the past given White House support for a move toward electronic medical records, cost cutting, and initiatives focused on technological advancement. WebMD (NASDAQ: WBMD), which runs WebMD.com and Medscape.com, does not exactly operate in the EMR or cost management space, but it does provide healthcare information. Its websites serve as touchpoints more »
-
WebMD Tries for a Comeback
By Eric Novinson - March 5, 2012 | Tickers: GOOG, JNJ, WBMD
The WebMD (NASDAQ: WBMD) stock price has fallen from more than $58 a share in early 2011 to barely over $25 today. Considering this factor by itself, the company looks like a sell. Two other factors suggest that the company deserves a second look. Carl Icahn recently purchased a sizable fraction of WebMD's stock, and he has the experience to turn a faltering company around. WebMD made another decision more »
-
Dominant Player Doesn't Equal Profits
By Chad Henage - February 9, 2012 | Tickers: ACOM, WBMD
Investors sometimes forget that companies and stock values are not the same. Sometimes you have opportunity where the market undervalues what is going on. Other times the market has too high of expectations and the stock corrects, even when the company is doing fine. The latter situation is what is likely to happen to WebMD Health Corp. (NASDAQ: WBMD). According to the company they are the “leading provider of health information services...”. I normally like to own stocks in companies that lead their field, but this situation appears different.
-
8 Next Tech Growth Kings (Part 2)
By Michael French - January 30, 2012 | Tickers: CRM, TZOO, WBMD, XLNX
This is a continuation from Part 1.
Xilinx, Inc. (NASDAQ: XLNX) – This has been a long-time favorite of many investors and is unusual in that the company has a nearly perfect twin, Altera Corp. (ALTR). While there are some critical differences that are discussed below, the similarities present an argument that both stocks should be included in a long-term core portfolio.
In terms of valuation metrics, XLNX has a price-to-earnings more »
-
END, WBMD: Heavy Insider Accumulation
By Brian Gorban - January 24, 2012 | Tickers: END, WBMD
There are many ways to screen for the right stock. Many use valuation metrics, while others look at technical analysis among a plethora of other methods and strategies. One of the best indicators I’ve seen is large buying in companies by people who have an existing large ownership stake, as it is always nice when people who have arguably the best view of the future of the company put more »
-
WBMD, VLNC: Should we Follow the Insiders?
By Brian Gorban - January 19, 2012 | Tickers: VLNCQ.PK, WBMD
There are many ways to screen for the right stock. Many use valuation metrics, while others look at technical analysis among a plethora of other methods and strategies. One of the best indicators I’ve seen is insider buying as it is always nice when people who have arguably the best view of the future of the company put their own money at risk alongside us investors. The following are more »
-
Goodbye, Jerry. Hello, Scott.
By George Liu - January 17, 2012 | Tickers: CMCSA, MSFT, NFLX, WBMD, YHOO
Yahoo! Inc. (NASDAQ: YHOO) announced today that Jerry Yang, its co-founder, has resigned from its Board of Directors and all other positions with the company, including Boards of Yahoo Japan and Alibaba Group Holding Limited, effective today. This is the latest in a series of significant management changes Yahoo has had to weather.
In early January, Yahoo hired executive search firm Heidrick & Struggles International to smooth out a corporate-level transition more »
-
Icahn upping his stake in this stock, should we?
By Brian Gorban - January 12, 2012 | Tickers: HOTT, WBMD
One of my favorite screening tools is to see stocks with notable insider buying. The reasoning is simple as insiders sell for many reasons (diversify one’s assets, pay for the new house, expensive trip with the family, unfortunate divorce settlement costs, etc.), but they buy only for one reason: to make more money. Therefore, these 2 stocks below caught my eye with their recent heavy insider buying.
-
WebMD Isn’t Dead Yet
By Tim Brugger - January 11, 2012 | Tickers: WBMD, YHOO
To say WebMD (NASDAQ: WBMD) took it on the chin yesterday is a monumental understatement. A 30% drop in share price in one day has many investors wondering what’s next for the beleaguered $1.5 billion online health information firm. And rightfully so.
What Happened
Before we tackle what’s on the horizon for WebMD, a quick look at what started all the commotion is in order. Mondays are more »